Akèy › Hypertension artérielle › Texas
Etid klinik pou Hypertension artérielle nan Texas
27 etid pou Hypertension artérielle ap chèche patisipan nan sit nan Texas.
Vil nan Texas
- Dallas16 etid
- Houston11 etid
- San Antonio7 etid
- Austin6 etid
- The Woodlands5 etid
- Arlington3 etid
- El Paso3 etid
- Fort Worth3 etid
Tèks ofisyèl etid la (Anglè)
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, Bellaire
- Retension Clinical Site, Dallas
- Retension Clincal Site, Plano
- ak 2 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07142356BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- Baylor Scott & White Research Institute, Dallas
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06059638A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Horizon Clinical Research Group, Cypress
- Cardiovascular Specialists of Willowbrook, Houston
- Texas Cardiology Associates of Houston, Kingwood
- ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Clinical Research - Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Headlands Research - Brownsville, Brownsville
- ak 25 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
- Laguna Clinical Research Associates, Laredo
- Tapia Internal Medicine Clinic, Paris
- Baylor Scott and White Research Institute - Temple, Temple
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07511361A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- IMA Clinical Research Austin, Austin
- Headlands Horizons, LLC dba Headlands Research-Brownsville, Brownsville
- Cedar Health Research - Texas Native Health, Dallas
- ak 10 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Arlington
- Research Site, Austin
- Research Site, Austin
- ak 8 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- Plaza Medical Center of Fort Worth, Fort Worth
- Houston Medical Center, Houston
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Allen
- Clinical Trial Site, Amarillo
- Clinical Trial Site, Amarillo
- ak 43 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
- University of Texas Southwestern Medical Center, Dallas
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Sep 3, 2026 · NCT04838678IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
- Parkland Hospital, Dallas
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Fanm · Mizajou Sep 2, 2026 · NCT06218355Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Dell Children's Medical Center of Central Texas, Austin
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 a 20 · Tout sèks · Mizajou Aug 21, 2026 · NCT04278404Global Paradise System US Post Approval Study
- Ascension Seton, Austin
- Dallas VAMC, Dallas
- TCR Institute, Kingwood
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
- UT Southwestern Medical Center, Dallas
- University of Texas Health Science Center San Antonio, San Antonio
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Aug 7, 2026 · NCT06402968Polypill for Prevention of Cardiomyopathy
- UT Southwestern Medical Center, Dallas
Ap rekriteFaz 1/2
Laj 18 a 100 · Tout sèks · Mizajou Aug 4, 2026 · NCT06143566A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07610278An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Sun Research Institute, San Antonio
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07543120A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
- Zenos Clinical Research, Dallas
- Aavon Clinical Trials, Houston
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06843577Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 20, 2026 · NCT04163614SPYRAL GEMINI Pilot Study
- Baylor Heart & Vascular Hospital, Dallas
- UT Health East Texas, Tyler
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
- University of Texas Medical Branch, Galveston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT05955339The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
- 3100 Cleburne Street, Nabrit Science Building,, Houston
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT07413159PRESSURE CHECK: Find Your Path to Better Health
- Houston Methodist, Houston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT06122246Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Carrollton
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2026 · NCT07090161Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
- UT Southwestern Medical Center, Dallas
Ap rekrite
Laj 18 a 60 · Tout sèks · Mizajou Feb 10, 2026 · NCT05168605Preventing Cognitive Decline by Reducing BP Target Trial
- UT Southwestern Medical Center, Dallas
Ap rekrite
Laj 70 ak plis · Tout sèks · Mizajou Dec 3, 2025 · NCT05106036Targeting Endoplasmic Reticulum Stress in Human Hypertension
- University of North Texas Health Science Center, Fort Worth
Ap rekriteFaz 1/2
Laj 18 a 80 · Tout sèks · Mizajou Mar 28, 2025 · NCT06025630Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.